Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Breast Neoplasms 45Lung Neoplasms 29Neoplasms 26Colorectal Neoplasms 20Prostatic Neoplasms 14Hematologic Neoplasms 10Uterine Cervical Neoplasms 9Fatigue 9Anxiety Disorders 8Neoplasm Metastasis 7Lymphoma 7Hematopoietic and Lymphatic System Neoplasm 7Papillomavirus Infections 6Ovarian Neoplasms 5Multiple Myeloma 5Melanoma 5Head and Neck Neoplasms 5Gastrointestinal Neoplasms 5Depression 5Carcinoma, Non-Small-Cell Lung 5Skin Neoplasms 4Obesity-Related Malignant Neoplasm 4Obesity 4Motor Activity 4Hematopoietic and Lymphoid System Neoplasm 4Breast Carcinoma In Situ 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3

Interventions

Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Chemotherapy-Induced Peripheral Neuropathy × Educational Status × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡